List of Excipients in API DOXAZOSIN MESYLATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DOXAZOSIN MESYLATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | CELLULOSE ACETATE | |
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | FERRIC OXIDE RED | |
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | FERROSOFERRIC OXIDE | |
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | HYPROMELLOSE | |
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | MAGNESIUM STEARATE | |
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | POLYETHYLENE GLYCOL | |
| Roerig | CARDURA | doxazosin mesylate | 0049-2710 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DOXAZOSIN MESYLATE
Detailed excipient profiles for DOXAZOSIN MESYLATE
Excipient focus: ALUMINUM OXIDE
DOXAZOSIN MESYLATE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-739 |
| DOH CENTRAL PHARMACY | doxazosin mesylate | 53808-1107 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
DOXAZOSIN MESYLATE drug variants containing ANHYDROUS LACTOSE
DOXAZOSIN MESYLATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE ACETATE
DOXAZOSIN MESYLATE drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DOXAZOSIN MESYLATE drug variants containing CELLULOSE, MICROCRYSTALLINE
DOXAZOSIN MESYLATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 30
DOXAZOSIN MESYLATE drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-647 |
| PD-Rx Pharmaceuticals Inc | doxazosin mesylate | 55289-022 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 67544-273 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
DOXAZOSIN MESYLATE drug variants containing D&C YELLOW NO. 10
DOXAZOSIN MESYLATE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 2
DOXAZOSIN MESYLATE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | doxazosin mesylate | 33261-658 |
| PD-Rx Pharmaceuticals Inc | doxazosin mesylate | 55289-600 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 67544-273 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
DOXAZOSIN MESYLATE drug variants containing FD&C YELLOW NO. 6
DOXAZOSIN MESYLATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
DOXAZOSIN MESYLATE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
DOXAZOSIN MESYLATE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
DOXAZOSIN MESYLATE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing HYPROMELLOSE
Excipient focus: LACTOSE
DOXAZOSIN MESYLATE drug variants containing LACTOSE
DOXAZOSIN MESYLATE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
DOXAZOSIN MESYLATE drug variants containing LACTOSE MONOHYDRATE
DOXAZOSIN MESYLATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
DOXAZOSIN MESYLATE drug variants containing MAGNESIUM STEARATE
DOXAZOSIN MESYLATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
DOXAZOSIN MESYLATE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: SHELLAC
DOXAZOSIN MESYLATE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
DOXAZOSIN MESYLATE drug variants containing SILICON DIOXIDE
DOXAZOSIN MESYLATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
DOXAZOSIN MESYLATE drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM LAURYL SULFATE
DOXAZOSIN MESYLATE drug variants containing SODIUM LAURYL SULFATE
DOXAZOSIN MESYLATE drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
DOXAZOSIN MESYLATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | doxazosin mesylate | 59651-892 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
DOXAZOSIN MESYLATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
DOXAZOSIN MESYLATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
DOXAZOSIN MESYLATE drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
DOXAZOSIN MESYLATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: STARCH, CORN
DOXAZOSIN MESYLATE drug variants containing STARCH, CORN
DOXAZOSIN MESYLATE drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
DOXAZOSIN MESYLATE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
DOXAZOSIN MESYLATE drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
